50 mg
Trade Name
Lacine
Film-coated tablet
Request Type
New Registration
Drug Type
Generic(Multisource) Drug
Approval Date
SFDA Approved Use
Treatment of essential hypertension in adults and in children and adolescents 6 – 18 years of age.
· Treatment of renal disease in adult patients with hypertension and type 2 diabetes mellitus with proteinuria ≥ 0.5 g/day as part of an antihypertensive treatment
· Reduction in the risk of stroke in adult hypertensive patients with left ventricular hypertrophy documented by ECG.
· Treatment of renal disease in adult patients with hypertension and type 2 diabetes mellitus with proteinuria ≥ 0.5 g/day as part of an antihypertensive treatment
· Reduction in the risk of stroke in adult hypertensive patients with left ventricular hypertrophy documented by ECG.